title: Basic fibroblast growth factor positively regulates hematopoietic development.
abstract: Recently identified BLast Colony Forming Cells (BL-CFCs) from in vitro differentiated embryonic stem (ES) cells represent the common progenitor of hematopoietic and endothelial cells, the hemangioblast. Access to this initial cell population committed to the hematopoietic lineage provides a unique opportunity to characterize hematopoietic commitment events. Here, we show that BL-CFC expresses the receptor tyrosine kinase, Flk1, and thus we took advantage of the BL-CFC assay, as well as fluorescent activated cell sorter (FACS) analysis for Flk1(+) cells to determine quantitatively if mesoderm-inducing factors promote hematopoietic lineage development. Moreover, we have analyzed ES lines carrying targeted mutations for fibroblast growth factor receptor-1 (fgfr1), a receptor for basic fibroblast growth factor (bFGF), as well as scl, a transcription factor, for their potential to generate BL-CFCs and Flk1(+) cells, to further define events leading to hemangioblast development. Our data suggest that bFGF-mediated signaling is critical for the proliferation of the hemangioblast and that cells expressing both Flk1 and SCL may represent the hemangioblast.
authors.affiliation: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
authors.forename: P
authors.initials: P
authors.lastname: Faloon
authors.forename: E
authors.initials: E
authors.lastname: Arentson
authors.forename: A
authors.initials: A
authors.lastname: Kazarov
authors.forename: C X
authors.initials: CX
authors.lastname: Deng
authors.forename: C
authors.initials: C
authors.lastname: Porcher
authors.forename: S
authors.initials: S
authors.lastname: Orkin
authors.forename: K
authors.initials: K
authors.lastname: Choi
mesh_terms: D028341:Activins; D051792:Basic Helix-Loop-Helix Proteins; D002452:Cell Count; D002454:Cell Differentiation; D002460:Cell Line; D004268:DNA-Binding Proteins / Q000235:genetics; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology*; D005434:Flow Cytometry; D018507:Gene Expression Regulation, Developmental; D018390:Gene Targeting; D006410:Hematopoiesis / Q000235:genetics*; D006801:Humans; D007265:Inhibins / Q000494:pharmacology; D008648:Mesoderm / Q000378:metabolism; D009154:Mutation; D011518:Proto-Oncogene Proteins; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics / Q000378:metabolism; D051496:Receptor, Fibroblast Growth Factor, Type 1; D017468:Receptors, Fibroblast Growth Factor / Q000235:genetics / Q000378:metabolism; D017978:Receptors, Growth Factor / Q000235:genetics / Q000378:metabolism; D040262:Receptors, Vascular Endothelial Growth Factor; D015398:Signal Transduction; D013234:Stem Cells / Q000187:drug effects* / Q000502:physiology; D000073942:T-Cell Acute Lymphocytic Leukemia Protein 1; D014157:Transcription Factors
chemical_list: D028341:Activins; D051792:Basic Helix-Loop-Helix Proteins; D004268:DNA-Binding Proteins; D016222:Fibroblast Growth Factor 2; D007265:Inhibins; D011518:Proto-Oncogene Proteins; D020794:Receptor Protein-Tyrosine Kinases; D051496:Receptor, Fibroblast Growth Factor, Type 1; D017468:Receptors, Fibroblast Growth Factor; D017978:Receptors, Growth Factor; D040262:Receptors, Vascular Endothelial Growth Factor; D000073942:T-Cell Acute Lymphocytic Leukemia Protein 1; D014157:Transcription Factors; C067143:TAL1 protein, human; C496348:FGFR1 protein, human